Ran Tur‐Kaspa

5.1k total citations
134 papers, 3.9k citations indexed

About

Ran Tur‐Kaspa is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Ran Tur‐Kaspa has authored 134 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 95 papers in Hepatology, 82 papers in Epidemiology and 23 papers in Surgery. Recurrent topics in Ran Tur‐Kaspa's work include Hepatitis C virus research (61 papers), Hepatitis B Virus Studies (54 papers) and Liver Disease Diagnosis and Treatment (52 papers). Ran Tur‐Kaspa is often cited by papers focused on Hepatitis C virus research (61 papers), Hepatitis B Virus Studies (54 papers) and Liver Disease Diagnosis and Treatment (52 papers). Ran Tur‐Kaspa collaborates with scholars based in Israel, United States and United Kingdom. Ran Tur‐Kaspa's co-authors include David A. Shafritz, Ziv Ben‐Ari, Romy Zemel, Yosef Shaul, Robert D. Burk, Daniel Shouval, Jaqueline Sulkes, L. Bachmetov, Lior H. Katz and Meital Gal-Tanamy and has published in prestigious journals such as New England Journal of Medicine, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Ran Tur‐Kaspa

131 papers receiving 3.7k citations

Peers

Countries citing papers authored by Ran Tur‐Kaspa

Since Specialization

Citations

This map shows the geographic impact of Ran Tur‐Kaspa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ran Tur‐Kaspa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ran Tur‐Kaspa more than expected).

Fields of papers citing papers by Ran Tur‐Kaspa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ran Tur‐Kaspa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ran Tur‐Kaspa. The network helps show where Ran Tur‐Kaspa may publish in the future.

Co-authorship network of co-authors of Ran Tur‐Kaspa

This figure shows the co-authorship network connecting the top 25 collaborators of Ran Tur‐Kaspa. A scholar is included among the top collaborators of Ran Tur‐Kaspa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ran Tur‐Kaspa. Ran Tur‐Kaspa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rapid seroconversion and persistent functional IgG antibodies in severe COVID-19 patients correlates with an IL-12p70 and IL-33 signature 2021 ·Scientific Reports ·Ariel Munitz, Liat Edry‐Botzer, Michal Itan, Ran Tur‐Kaspa, Dror Dicker, (unknown), Moran G. Goren, Michael Mor, (unknown), Tamar Gottesman, Khitam Muhsen, Dani Cohen, Michal Stein, Udi Qimron, Natalia T. Freund, Yariv Wine, Motti Gerlic	25
2	The utility of magnetic resonance cholangiopancreatography for the assessment of patients with elevated liver enzyme levels 2013 ·European Journal of Gastroenterology & Hepatology ·Ofer Benjaminov, Gil N. Bachar, (unknown), (unknown), Ran Tur‐Kaspa	1
3	Inhibition of protease-inhibitor-resistant hepatitis C virus replicons and infectious virus by intracellular intrabodies 2010 ·Antiviral Research ·Meital Gal-Tanamy, Romy Zemel, (unknown), Rohit K. Jangra, Assaf Shapira, Rodrigo A. Villanueva, MinKyung Yi, Stanley M. Lemon, Itai Benhar, Ran Tur‐Kaspa	14
4	Endovascular Diagnosis and Intervention in Patients with Isolated Hyperammonemia, with or without Ascites, after Liver Transplantation 2008 ·Journal of Vascular and Interventional Radiology ·Alexander Belenky, (unknown), (unknown), Gil N. Bachar, (unknown), (unknown), Ziv Ben‐Ari, Ran Tur‐Kaspa, Eli Atar	1
5	Lamivudine prevents reactivation of hepatitis B and reduces mortality in immunosuppressed patients: systematic review and meta‐analysis 2007 ·Journal of Viral Hepatitis ·Lior H. Katz, Abigail Fraser, Anat Gafter‐Gvili, Leonard Leibovici, Ran Tur‐Kaspa	103
6	Serum globulin levels in predicting the extent of hepatic fibrosis in patients with recurrent post‐transplant hepatitis C infection 2007 ·Clinical Transplantation ·Hemda Schmilovitz‐Weiss, Michal Cohen, Orit Pappo, Jaqueline Sulkes, Marius Braun, Ran Tur‐Kaspa, Ziv Ben‐Ari	11
7	Iatrogenic Transmission of Hepatitis C Virus (HCV) by an Anesthesiologist: Comparative Molecular Analysis of the HCV-E1 and HCV-E2 Hypervariable Regions 2007 ·Clinical Infectious Diseases ·Yonat Shemer‐Avni, Michal Cohen, Ayelet Keren‐Naus, Emanuel Sikuler, (unknown), A. Yaari, (unknown), (unknown), Romy Zemel, Ran Tur‐Kaspa	19
8	Chronic Hepatitis C Virus Infection in Older Adults 2005 ·Clinical Infectious Diseases ·Kevin P. High, Esther‐Lee Marcus, Ran Tur‐Kaspa	25
9	HCV NS3 Serine Protease-neutralizing Single-chain Antibodies Isolated by a Novel Genetic Screen 2005 ·Journal of Molecular Biology ·Meital Gal-Tanamy, Romy Zemel, Yevgeny Berdichevsky, (unknown), Ran Tur‐Kaspa, Itai Benhar	19
10	Lamivudine treatment for acute severe hepatitis B: a pilot study 2004 ·Liver International ·Hemda Schmilovitz‐Weiss, Ziv Ben‐Ari, Emanuel Sikuler, Eli Zuckerman, Wisam Sbeit, Zvi Ackerman, Rifaat Safadi, Yoav Lurie, Guy Rosner, Ran Tur‐Kaspa, Ron Reshef	57
11	Conservative Treatment of Prosthetic Valve Endocarditis due to Mycobacterium fortuitum 2002 ·European Journal of Clinical Microbiology & Infectious Diseases ·Margarita Kunin, (unknown), Miriam Weinberger, (unknown), Alik Sagie, Ran Tur‐Kaspa	11
12	Long-term experience with lamivudine therapy for hepatitis B virus infection after liver transplantation 2001 ·Liver Transplantation ·Ziv Ben‐Ari, Eytan Mor, (unknown), Ran Tur‐Kaspa	33
13	Efficacy of Lamivudine in Patients With Hepatitis B Virus Precore Mutant Infection Before and After Liver Transplantation 1999 ·The American Journal of Gastroenterology ·Ziv Ben‐Ari, Romy Zemel, (unknown), Gerald Fraser, Ran Tur‐Kaspa	18
14	Hepatitis C infection in renal transplant recipients in Israel 1997 ·Transplantation Proceedings ·Talia Weinstein, D Zevin, Yaacov Ori, Asher Korzets, Avry Chagnac, Michal Herman, Ran Tur‐Kaspa, Uzi Gafter	1
15	Utilization of liver allografts from donors older than 60 in Israel: Benefits and risks 1997 ·Transplantation Proceedings ·E. Mor, D Shmueli, N Bar-Nathan, (unknown), A Yussim, Ziv Ben Ari, Ran Tur‐Kaspa, Z Shapira	4
16	A 5-year experience in liver transplantation at Rabin Medical Center, Israel 1997 ·Transplantation Proceedings ·E Shaharabani, E. Mor, (unknown), D Shmueli, (unknown), Richard Nakache, Ziv Ben‐Ari, (unknown), (unknown), Boris Sobolev, Ran Tur‐Kaspa, (unknown)	1
17	DisseminatedNocardia transvalensis infection resembling pulmonary infarction in a liver transplant recipient 1995 ·European Journal of Clinical Microbiology & Infectious Diseases ·Miriam Weinberger, Ahmed Eid, (unknown), Mark Shapiro, Yaron Ilan, E Libson, T. Sacks, Ran Tur‐Kaspa	8
18	Acquired hepatocerebral degeneration in a liver transplant recipient 1995 ·Acta Neuropathologica ·Dov Soffer, Yoav Sherman, Ran Tur‐Kaspa, Ahmed Eid	18
19	Idiopathic Unconjugated Hyperbilirubinemia (Gilbert's Syndrome) and Concurrent Psychotropic Drug Administration 1993 ·Pharmacopsychiatry ·Rimona Durst, (unknown), A Dorevitch, L. Kikinzon, Ran Tur‐Kaspa	8
20	Relapsing Hepatitis A Review of 14 Cases and Literature Survey 1992 ·Medicine ·Michael Glikson, Eithan Galun, Ran Oren, Ran Tur‐Kaspa, Daniel Shouval	127

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact